Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Virtanen JK, Mursu J, Voutilainen S, Uusitupa M, Tuomainen T-P
When GLP-1 receptors activate in the brain, they trigger satiety signals that decrease hunger and food-seeking behavior
Novo Nordisk, the current market leader with a 55.1% value share in GLP-1s, faces increasing pressure from Eli Lilly, which has been gaining market share since mid-2024
Weekly dosing is possible because the drugs are engineered with fatty acid chains that bind to albumin in the blood, extending their half-life
China Demand for GLP-1 receptor agonists in China is projected to rise at 7.1% CAGR through 2036
US$ 23.58
US$ 26.13
US$ 26.47
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 20.67
US$ 28.50
